• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于抗疟活性的氧杂蒽酮类化合物的优化:3,6-双-ω-二乙氨基烷氧基氧杂蒽酮系列

Optimization of xanthones for antimalarial activity: the 3,6-bis-omega-diethylaminoalkoxyxanthone series.

作者信息

Kelly Jane Xu, Winter Rolf, Peyton David H, Hinrichs David J, Riscoe Michael

机构信息

Department of Chemistry, Portland State University, Portland, Oregon 97207-0751, USA.

出版信息

Antimicrob Agents Chemother. 2002 Jan;46(1):144-50. doi: 10.1128/AAC.46.1.144-150.2002.

DOI:10.1128/AAC.46.1.144-150.2002
PMID:11751125
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC126978/
Abstract

Hydroxyxanthones have been identified as novel antimalarial agents. The compounds are believed to exert their activity by complexation to heme and inhibition of hemozoin formation. Modification of the xanthone structure was pursued to improve their antimalarial activity. Attachment of R-groups bearing protonatable nitrogen atoms was conducted to enhance heme affinity through ionic interactions with the propionate side chains of the metalloporphyrin and to facilitate drug accumulation in the parasite food vacuole. A series of 3,6-bis-omega-diethylaminoalkoxyxanthones with side chains ranging from 2 to 8 carbon atoms were prepared and evaluated. Measurement of heme affinity for each of the derivatives revealed a strong correlation (R(2) = 0.97) between affinity and antimalarial potency. The two most active compounds in the series contained 5- and 6-carbon side chains and exhibited low nanomolar 50% inhibitory concentration (IC(50)) values against strains of chloroquine-susceptible and multidrug-resistant Plasmodium falciparum in vitro. Both of these xanthones exhibit stronger heme affinity (8.26 x 10(5) and 9.02 x 10(5) M(-1), respectively) than either chloroquine or quinine under similar conditions and appear to complex heme in a unique manner.

摘要

羟基氧杂蒽酮已被确认为新型抗疟药物。据信这些化合物通过与血红素络合并抑制疟原虫色素形成来发挥其活性。人们对氧杂蒽酮结构进行修饰以提高其抗疟活性。通过连接带有可质子化氮原子的R基团,以通过与金属卟啉的丙酸侧链的离子相互作用增强血红素亲和力,并促进药物在寄生虫食物泡中的积累。制备并评估了一系列侧链碳原子数从2到8的3,6-双-ω-二乙氨基烷氧基氧杂蒽酮。对每种衍生物的血红素亲和力的测量显示亲和力与抗疟效力之间存在强相关性(R(2) = 0.97)。该系列中活性最高的两种化合物含有5个和6个碳原子的侧链,在体外对氯喹敏感和多药耐药的恶性疟原虫菌株表现出低纳摩尔的50%抑制浓度(IC(50))值。在类似条件下,这两种氧杂蒽酮均比氯喹或奎宁表现出更强的血红素亲和力(分别为8.26 x 10(5)和9.02 x 10(5) M(-1)),并且似乎以独特的方式与血红素络合。

相似文献

1
Optimization of xanthones for antimalarial activity: the 3,6-bis-omega-diethylaminoalkoxyxanthone series.用于抗疟活性的氧杂蒽酮类化合物的优化:3,6-双-ω-二乙氨基烷氧基氧杂蒽酮系列
Antimicrob Agents Chemother. 2002 Jan;46(1):144-50. doi: 10.1128/AAC.46.1.144-150.2002.
2
Xanthones as antimalarial agents; studies of a possible mode of action.氧杂蒽酮类作为抗疟剂;作用方式的可能研究。
FEBS Lett. 1997 Jun 2;409(1):67-73. doi: 10.1016/s0014-5793(97)00405-5.
3
A spectroscopic investigation of the binding interactions between 4,5-dihydroxyxanthone and heme.4,5-二羟基呫吨酮与血红素结合相互作用的光谱研究。
J Inorg Biochem. 2001 Sep;86(2-3):617-25. doi: 10.1016/s0162-0134(01)00217-3.
4
Xanthones as antimalarial agents: stage specificity.
Am J Trop Med Hyg. 2000 Jan;62(1):77-81. doi: 10.4269/ajtmh.2000.62.77.
5
The kinetics of uptake and accumulation of 3,6-bis-omega-diethylamino-amyloxyxanthone by the human malaria parasite Plasmodium falciparum.人类疟原虫恶性疟原虫对3,6-双-ω-二乙氨基淀粉氧基呫吨酮的摄取和积累动力学
Mol Biochem Parasitol. 2002 Aug 7;123(1):47-54. doi: 10.1016/s0166-6851(02)00118-4.
6
Antimalarial xanthones from Garcinia cowa.来自柯氏藤黄的抗疟呫吨酮类化合物。
Planta Med. 1998 Feb;64(1):70-2. doi: 10.1055/s-2006-957370.
7
Synthesis and heme-binding correlation with antimalarial activity of 3,6-bis-(omega-N,N-diethylaminoamyloxy)-4,5-difluoroxanthone.3,6-双-(ω-N,N-二乙氨基烷氧基)-4,5-二氟呫吨酮的合成及其与抗疟活性的血红素结合相关性
Bioorg Med Chem. 2008 Feb 1;16(3):1174-83. doi: 10.1016/j.bmc.2007.10.083. Epub 2007 Nov 26.
8
N,N-Bis(trifluoromethylquinolin-4-yl)diamino alkanes: synthesis and antimalarial activity.N,N-双(三氟甲基喹啉-4-基)二氨基烷烃:合成与抗疟活性
Med Chem. 2008 Sep;4(5):438-45. doi: 10.2174/157340608785700216.
9
Synthesis and antimalarial properties of new chloro-9H-xanthones with an aminoalkyl side chain.具有氨基烷基侧链的新型氯代-9H-呫吨酮的合成及其抗疟特性
Chem Biodivers. 2007 Jul;4(7):1508-19. doi: 10.1002/cbdv.200790130.
10
Interference with heme binding to histidine-rich protein-2 as an antimalarial strategy.干扰血红素与富含组氨酸蛋白-2的结合作为一种抗疟策略。
Chem Biol. 2002 Aug;9(8):881-9. doi: 10.1016/s1074-5521(02)00183-7.

引用本文的文献

1
In vivo antimalarial effect of 1-hydroxy-5,6,7-trimethoxyxanthone isolated from Mammea siamensis T. Anders. flowers: pharmacokinetic and acute toxicity studies.从暹罗杨梅的花中分离得到的 1-羟基-5,6,7-三甲氧基呫吨酮的体内抗疟效果:药代动力学和急性毒性研究。
BMC Complement Med Ther. 2024 Mar 23;24(1):129. doi: 10.1186/s12906-024-04427-z.
2
Identification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum.对恶性疟原虫具有活性的疟原虫色素抑制苯甲酰胺类化合物的鉴定与构效关系评估
J Med Chem. 2016 Jul 14;59(13):6512-30. doi: 10.1021/acs.jmedchem.6b00719. Epub 2016 Jun 24.
3
Hemozoin and antimalarial drug discovery.血晶素与抗疟药物研发。
Future Med Chem. 2013 Aug;5(12):1437-50. doi: 10.4155/fmc.13.113.
4
Biological activities of nitidine, a potential anti-malarial lead compound.尼啶碱的生物活性,一种有潜力的抗疟先导化合物。
Malar J. 2012 Mar 9;11:67. doi: 10.1186/1475-2875-11-67.
5
Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria.恶性疟原虫对喹啉类药物耐药性的分子与生理基础
Future Microbiol. 2009 May;4(4):441-55. doi: 10.2217/fmb.09.15.
6
Leishmanicidal and cholinesterase inhibiting activities of phenolic compounds from Allanblackia monticola and Symphonia globulifera.蒙氏 Allanblackia 和球花 Symphonia 中酚类化合物的杀利什曼原虫活性及胆碱酯酶抑制活性
Molecules. 2007 Jul 20;12(8):1548-57. doi: 10.3390/12081548.
7
Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.10-N-取代吖啶酮作为恶性疟原虫新型化学增敏剂的设计、合成与评价
Antimicrob Agents Chemother. 2007 Nov;51(11):4133-40. doi: 10.1128/AAC.00669-07. Epub 2007 Sep 10.
8
Selective killing of the human malaria parasite Plasmodium falciparum by a benzylthiazolium dye.一种苄基噻唑鎓染料对人类疟原虫恶性疟原虫的选择性杀伤作用。
Exp Parasitol. 2007 Jun;116(2):103-10. doi: 10.1016/j.exppara.2006.12.001. Epub 2006 Dec 21.
9
Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.用于高通量抗疟药物筛选的简单且低成本的荧光技术。
Antimicrob Agents Chemother. 2004 May;48(5):1803-6. doi: 10.1128/AAC.48.5.1803-1806.2004.

本文引用的文献

1
The plasmodium digestive vacuole: metabolic headquarters and choice drug target.疟原虫消化泡:代谢总部及理想药物靶点
Parasitol Today. 1995 Aug;11(8):294-7. doi: 10.1016/0169-4758(95)80042-5.
2
The Soret band of monomeric hematin and its changes on polymerization.单体血红素的索雷特带及其在聚合过程中的变化。
Biochem Biophys Res Commun. 1962 Oct 31;9:323-7. doi: 10.1016/0006-291x(62)90048-7.
3
A spectroscopic investigation of the binding interactions between 4,5-dihydroxyxanthone and heme.4,5-二羟基呫吨酮与血红素结合相互作用的光谱研究。
J Inorg Biochem. 2001 Sep;86(2-3):617-25. doi: 10.1016/s0162-0134(01)00217-3.
4
Chloroquine-resistant malaria.氯喹抗性疟疾
J Infect Dis. 2001 Sep 15;184(6):770-6. doi: 10.1086/322858. Epub 2001 Aug 7.
5
Functional analysis of drug resistance in Plasmodium falciparum in the post-genomic era.后基因组时代恶性疟原虫耐药性的功能分析
Int J Parasitol. 2001 Jul;31(9):871-8. doi: 10.1016/s0020-7519(01)00201-6.
6
Mode of action and mechanisms of resistance for antimalarial drugs.抗疟药物的作用方式和耐药机制。
Pharmacol Ther. 2001 Feb;89(2):207-19. doi: 10.1016/s0163-7258(00)00115-7.
7
The mechanism of beta-hematin formation in acetate solution. Parallels between hemozoin formation and biomineralization processes.β-血红素在醋酸盐溶液中的形成机制。疟原虫色素形成与生物矿化过程之间的相似性。
Biochemistry. 2001 Jan 9;40(1):204-13. doi: 10.1021/bi0013501.
8
Characterization of chloroquine-hematin mu-oxo dimer binding by isothermal titration calorimetry.通过等温滴定量热法表征氯喹-血红素μ-氧代二聚体结合
Biochim Biophys Acta. 2000 Jul 3;1475(2):133-40. doi: 10.1016/s0304-4165(00)00058-1.
9
The structure of malaria pigment beta-haematin.疟色素β-血红素的结构。
Nature. 2000 Mar 16;404(6775):307-10. doi: 10.1038/35005132.
10
Averting a malaria disaster.避免疟疾灾难。
Lancet. 1999 Jun 5;353(9168):1965-7. doi: 10.1016/s0140-6736(98)07367-x.